Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.43 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6821250 | 0.85 | ALDH1A1 (0.50) | ALDH1A1PAOXS1PR2S1PR1S1PR3 | |
| SCHEMBL21499623 | 0.85 | ALDH1A1 (0.53) | ALDH1A1PAOXS1PR2S1PR1S1PR3 | |
| SCHEMBL18648402 | 0.83 | PAOX (0.56) | ALDH1A1PAOXS1PR2S1PR1S1PR3 | |
| SCHEMBL1873964 | 0.83 | ALDH1A1 (0.96) | ALDH1A1ENPEPFFAR4FFAR1 | |
| SCHEMBL1879784 | 0.82 | ALDH1A1 (1.00) | ALDH1A1ENPEPFFAR4FFAR1 | |
| SCHEMBL1882504 | 0.82 | ALDH1A1 (1.00) | ALDH1A1ENPEPFFAR4FFAR1 | |
| SCHEMBL1877009 | 0.82 | ALDH1A1 (1.00) | ALDH1A1ENPEPFFAR4FFAR1 | |
| SCHEMBL8113493 | 0.82 | ALDH1A1 (1.00) | ALDH1A1ENPEPFFAR4FFAR1 | |
| SCHEMBL1878242 | 0.82 | ALDH1A1 (1.00) | ALDH1A1ENPEPFFAR4FFAR1 | |
| SCHEMBL1878344 | 0.82 | ALDH1A1 (1.00) | ALDH1A1ENPEPFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8512755-B2 | Compact multifunctional ligand to enhance colloidal stability of nanoparticles | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-08-20 | — | — | US | disclosed |
| US-20130045499-A1 | Compact Multifunctional Ligand to Enhance Colloidal Stability of Nanoparticles | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045499-A1 | Compact Multifunctional Ligand to Enhance Colloidal Stability of Nanoparticles | EPCAM, SLC7A1, CAD | ALDH1A1 2504/4885PAOX 4111/4885S1PR2 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.